Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosis. (Q48336769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

7 December 2019

main subject

0 references

multiple sclerosis

0 references

author

Tatiana Koudriavtseva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

C Pozzilli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Fiorelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Gasperini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Bagnato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Galgani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Frontoni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

O Ciccarelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Bastianello

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

403-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859800400501

10.1177/135245859800400501

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839299%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference